Over-treatment of Renal Tumors: The Turtle in the Room - Robert G. Uzzo
August 9, 2017
Kidney cancer, like all cancers, has a spectrum of risk. There are groups of patients with incidentally detected asymptomatic, small renal masses that act relatively indolent and are often over-diagnosed and over-treated in some patients. The issue is defining who they are when they should or should not be treated.
Watch: Adjuvant Therapies for Renal Cell Carcinoma - Robert Uzzo
Perioperative Systemic Therapy for Kidney Cancer: Current Data and Ongoing Trials
Best of Journals: Renal Cell Carcinoma – Urologic Oncology - Session Highlights
Robert G. Uzzo, MD
Chair, Department of Surgical Oncology
G. Willing "Wing" Pepper Chair in Cancer Research
Kidney, Bladder, and Prostate Cancer TRDG Member
Senior Vice-President, Physician Services
President, FCCC Medical Group, Inc.
Professor of Surgery, Temple University Health System
E. David Crawford